Trial Profile
ENDOTIC: Endothelium and Ticagrelor: Pharmacological effects beyond antiplatelet effect.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms ENDOTIC
- 15 Oct 2016 Status changed from recruiting to completed.
- 01 Aug 2014 New trial record